Is there a generic version of Sotorasib?

There are generic drugs of Sotorasib (Sotorasib). The pharmaceutical ingredients of the generic drugs are basically the same as those of the original drug of Sotorasib, but the manufacturers and production specifications are different, and the selling prices are different. Sotorracib is an oral medication that belongs to a class of drugs known as KRAS G12C inhibitors. KRAS gene mutations are common in a variety of cancers, including non-small cell lung cancer (NSCLC). NSCLC is one of the most common types of lung cancer, and G12C mutations in the KRAS gene account for a considerable proportion of them.

The mechanism of action of sotorasiib is by inhibiting the G12C mutation of the KRAS gene, which causes abnormal proliferation and growth of cancer cells. It binds to the mutated KRAS protein and blocks its activity, thereby interfering with the signaling pathways of cancer cells and reducing the proliferation ability of cancer cells. Common manufacturers of generic drugs of sotorasibu include Laos, Bangladesh, etc. The specifications produced by Laos Element Pharmaceuticals 120mg*56 tabletsThe price is around RMB 4,800, the specifications produced by Bangladesh Everest Pharmaceutical Factory are 120mg*56 tablets and the price is around 4800 RMB (the price may fluctuate due to the exchange rate), which is relatively cheap.

SotoracibThe original drug has not yet been launched in China, so it is not covered by medical insurance. Domestic patients cannot yet purchase this drug. The Hong Kong original research versionsotorasibuSpecifications120mg*240 tablets are priced at around RMB 80,000 (the price may fluctuate due to the exchange rate), and the European original research version 120mg*240 tablets are priced at around RMB 44,000 (the price may fluctuate due to the exchange rate), which is more expensive. For specific prices and drug details, please consult Yaode’s medical consultant.